SkinHealth Systems Inc. – Material Contracts Watch

from 8-K/A 6 pages Severance and General Release Agreement

from 8-K/A 5 pages General Release of All Claims

from 8-K/A 3 pages October 10, 2025 Marla Beck via Email Re: Separation of Employment Dear Marla

from 8-K 90 pages Material contract

from 8-K 167 pages The Beauty Health Company [Form Of] Exchange Agreement May 21, 2025

from 8-K 2 pages Certain Information, Identified by [*****], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material, and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed March 25, 2024 Sheri Lewis [*****]

from 8-K 2 pages Certain Information, Identified by [*****], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material, and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed October 9, 2024 Ron Menezes [*****]

from 8-K/A 7 pages Separation and Transition Agreement

from 10-Q 3 pages Material contract

from 10-Q 8 pages \\\DC - 71532/300 - #1291878 V5 Purchase Agreement Purchase Agreement, Dated April 1, 2024 (The “Purchase Agreement”), Between The Beauty Health Company (The “Purchaser”) and Goldman Sachs & Co. LLC (The “Dealer”). Whereas, Purchaser Desires That Dealer Effect Purchases of the Purchaser’s 1.25% Convertible Senior Notes Due 2026, (The “Bonds”) for in Total, but Not Exceeding, $100 Million for Resale to the Purchaser; and Whereas, the Parties Intend That the Purchases of Bonds Made Pursuant to This Purchase Agreement Shall Comply With the Requirements of Rule 10b5-1(c)(1)(i) Under the Securities Exchange Act of 1934 (“Exchange Act”), and That This Purchase Agreement Shall Be Interpreted to Comply With the Requirements of That Rule. Now Therefore, the Purchaser and Dealer Hereby Agree as Follows: 1. Dealer Shall Effect One or More Purchases (Each a “Purchase”) of Bonds as Set Forth on Annex A, and the Purchaser Shall, Upon Each Such Purchase, Effect a Purchase (Each, a “Purchaser’s Purchase”) From Dealer of the Bonds That Are the Subject of Such Purchase at the Same Price at Which Dealer Purchased Such Bonds Plus 0.25% (The “Spread”). Dealer’s Sole Compensation for Services Rendered Under This Purchase Agreement Shall Be the Spread on Each Such Purchase by the Purchaser. 2. This Purchase Agreement Shall Become Effective on April 9, 2024 and Shall Terminate on the Earliest Of: (I) the Date an Aggregate Purchase Amount of $100 Million Has Been Purchased Pursuant to This Purchase Agreement; (II) the Date That Any Person Publicly Announces a Tender or Exchange Offer With Respect to the Bonds; (III) the Date of Public Announcement of a Merger, Acquisition, Reorganization, Recapitalization or Comparable Transaction Affecting the Securities of the Purchaser as a Result of Which the Bonds Are to Be Exchanged or Converted Into

from 10-Q 8 pages \\\DC - 71532/300 - #1291878 V5 Purchase Agreement Purchase Agreement, Dated December 15, 2023 (The “Purchase Agreement”), Between The Beauty Health Company (The “Purchaser”) and Goldman Sachs & Co. LLC (The “Dealer”). Whereas, Purchaser Desires That Dealer Purchase as Principal Up to $75 Million Principal Amount of the Purchaser’s 1.25% Convertible Senior Notes Due 2026, (The “Bonds”) for Resale to the Purchaser; and Whereas, the Parties Intend That the Purchases of Bonds Made Pursuant to This Purchase Agreement Shall Comply With the Requirements of Rule 10b5-1(c)(1)(i) Under the Securities Exchange Act of 1934 (“Exchange Act”), and That This Purchase Agreement Shall Be Interpreted to Comply With the Requirements of That Rule. Now Therefore, the Purchaser and Dealer Hereby Agree as Follows: 1. Dealer Shall Effect One or More Purchases (Each a “Purchase”) of Bonds as Set Forth on Annex A, and the Purchaser Shall, Upon Each Such Purchase, Effect a Purchase (Each, a “Purchaser’s Purchase”) From Dealer of the Bonds That Are the Subject of Such Purchase at the Same Price at Which Dealer Purchased Such Bonds Plus 0.25% (The “Spread”). Dealer’s Sole Compensation for Services Rendered Under This Purchase Agreement Shall Be the Spread on Each Such Purchase by the Purchaser. 2. This Purchase Agreement Shall Become Effective on December 18, 2023 and Shall Terminate on the Earliest Of: (I) the Date an Aggregate Principal Amount of $75 Million Bonds Have Been Purchased Pursuant to This Purchase Agreement; (II) the Date That Any Person Publicly Announces a Tender or Exchange Offer With Respect to the Bonds; (III) the Date of Public Announcement of a Merger, Acquisition, Reorganization, Recapitalization or Comparable Transaction

from 8-K/A 7 pages Separation, Transition and General Release Agreement

from 8-K 16 pages Material contract

from 8-K 35 pages Material contract

from 8-K/A 29 pages Certain Information, Identified by [*****], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material, and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed December 8, 2023 Andrew Stanleick via Email Re: Separation of Employment

from 8-K 6 pages The Beauty Health Company 2021 Incentive Award Plan Restricted Stock Unit Grant Notice

from 8-K 27 pages Material contract

from 8-K 3 pages Certain Information, Identified by [*****], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material, and (II) Would Likely Cause Competitive Harm to the Company if Publicly Disclosed August 3, 2023 Liyuan Woo via Email Re: Separation of Employment Dear Liyuan

from 8-K 30 pages Employment Agreement

from 8-K 1 page April 7, 2023 Dear Brad, Congratulations on Your Promotion to Your New Role as Chief Operating Officer! In This Role You Will Continue to Report Directly to Me and Will Remain a Member of the Executive Committee. Based on Your Promotion, the Board of Directors Has Approved Your New Annual Salary of $475,000. This Amount, Less Applicable Withholdings and Deductions Will Be Effective April 19, 2023